Cancilico
The company develops AI-driven diagnostic solutions for haematology to automate and improve the accuracy of blood and bone marrow analysis.
Dresden, Germanycancilico.com ↗
Total raised
€2.5M
€2,500,000
Funding rounds
1
Investors
4
distinct backers
Active since
2026-01
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood28
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-20 | Seed | €2.5M | GEDAD GmbH,High-Tech Gründerfonds (HTGF),ROI Verwaltungsgesellschaft,TGFS - Technologiegründerfonds Sachsen | View deal → |
Investors
4Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software